Authors: Nelms C.; Carter K.; Meier G.; Gayle R.; Parent F.N.; Demasi R.; Marcinczyk M.

Source: Journal for Vascular Ultrasound, Volume 27, Number 2, 1 June 2003 , pp. 88-92(5)

Publisher: Society for Vascular Ultrasound

Abstract:

Introduction.—Color duplex ultrasound (CDU) is routinely used in the evaluation of aortic endografts in many centers. CDU compliments computed tomography (CT) and selective angiography in the identification of persistent endoleaks in these grafts. Because of the complexity of these procedures and the subtle nature of endoleaks, CDU can be time-consuming and challenging. Contrast agents can improve the ease of imaging by rapidly detecting low flow endoleaks. The application of ultrasound contrast agents has been studied in other specialties, such as cardiac echocardiography. This article describes our technique and early experience using contrast-enhanced CDU in aortic endograft assessment.

Methods.—Nineteen patients being seen for a routine CDU examination after endovascular aortic aneurysm repair were evaluated according to published protocol. An initial CDU examination was completed, thoroughly assessing for the presence of graft patency, limb dysfunction, and endoleak. After patient consent, a focused ultrasound was performed using a Food and Drug Administration-approved contrast agent (Optison). The residual aneurysm sac was closely inspected after a 0.3-ml intravenous injection. A maximum of three injections were given in 10-min intervals, with careful evaluation in transverse and sagittal views of the residual aortic sac. Contrast was used to confirm endoleaks noted on the baseline study and help clarify subtle perigraft flow, especially on suboptimal examinations.

Results.—Of the 19 patients given the contrast agent, none had side effects, and all tolerated contrast well. In 9 of 19 examinations, contrast-enhanced CDU confirmed the baseline results positive for perigraft endoleak. Six of nine studies had improved ease of identification of endoleak with contrast. Six of 19 studies were negative for endoleak before and after contrast. Three of 19 studies were indeterminate for endoleak by CDU only secondary to bowel gas and body habitus. The contrast agent was given and was negative for endoleak in these three cases. One study was initially negative for endoleak by CDU, and contrast revealed a small lumber artery leaking into the aneurysm sac. The contrast was easily identified within the endograft and leak sites in all patients.

Conclusions.—CDU is a valuable modality in the postoperative evaluation of endovascular aortic aneurysm repairs. These examinations can be challenging and subject to limitations including bowel gas and body habitus, even when performed by experienced technologists. Color artifacts within the residual aneurysm sac can be difficult to differentiate from true endoleak. Contrast-enhanced CDU can improve the technologist's confidence in the detection of endoleaks.

Document Type: Research article

Publication date: 2003-06-01

More about this publication?

• The Journal for Vascular Ultrasound (JVU) is the official journal of the Society for Vascular Ultrasound. It consists of original scientific and educational articles, case studies, book reviews, technical reviews, ultrasound principle reviews, viewpoints, letters to the editor, and CME tests. Regular reading of JVU, published quarterly, will keep you current in your field and provide essential information that can be applied in your practice.
  
  Previously known as the Journal of Vascular Technology - View Volumes 16-26 here
• Editorial Board
• Information for Authors
• Subscribe to this Title
• Membership Information
• Information for Advertisers
• Reprints
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Radiology & Imaging ,  Acoustics
• By this author: Nelms C. ;  Carter K. ;  Meier G. ;  Gayle R. ;  Parent F.N. ;  Demasi R. ;  Marcinczyk M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers